Isolation and identification of three new 5-alkenyl-3,3(2H)-furanones from two streptomyces species using a genomic screening approach. (Q34530626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Isolation and identification of three new 5-alkenyl-3,3(2H)-furanones from two streptomyces species using a genomic screening approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

Streptomyces albidoflavus

28 January 2020

main subject

Streptomyces aculeolatus

1 reference

1 reference

1 reference

inferred from

reverse claim

Streptomyces gramineus

1 reference

1 reference

1 reference

(2S)-5-[(2S,5E,7E,9S,10R,11E)-2,10-dihydroxy-9,11-dimethyltrideca-5,7,11-trienyl]-2-hydroxy-2-[(1S)-1-hydroxyethyl]-4-methylfuran-3-one

1 reference

inferred from

reverse claim

5-(2,10-Dihydroxy-9,11-dimethyltrideca-5,7,11-trienyl)-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one

1 reference

inferred from

reverse claim

5-(2,10-Dihydroxy-9,11-dimethyltetradeca-5,7,11-trienyl)-2-hydroxy-2-(1-hydroxyethyl)-4-methylfuran-3-one

1 reference

1 reference

5-(2,10-Dihydroxy-5,9,11-trimethyltrideca-5,7,11-trienyl)-2-hydroxy-2,4-dimethylfuran-3-one

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Chris M Farnet

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

2

James B Mcalpine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Arjun H Banskota

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Mustapha Aouidate

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Mahmood Piraee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Anne-Marie Alarco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kazuro Shiomi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Emmanuel Zazopoulos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Satoshi Omura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

March 2006

1 reference

full work available at URL

16 September 2022

https://www.nature.com/articles/ja200624.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2006.24?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

168-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2006.24?email=unpaywall_01@example.com

access restriction status

open access

1 reference

inferred from online access status

cites work

The role of natural product chemistry in drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

A genomics-guided approach for discovering and expressing cryptic metabolic pathways.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Microbial genomics as a guide to drug discovery and structural elucidation: ECO-02301, a novel antifungal agent, as an example.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

A80915, a new antibiotic complex produced by Streptomyces aculeolatus. Discovery, taxonomy, fermentation, isolation, characterization, and antibacterial evaluation

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Biosynthesis of the polyene antifungal antibiotic nystatin in Streptomyces noursei ATCC 11455: analysis of the gene cluster and deduction of the biosynthetic pathway.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Enhancement and selective production of phoslactomycin B, a protein phosphatase IIa inhibitor, through identification and engineering of the corresponding biosynthetic gene cluster

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Iteration as programmed event during polyketide assembly; molecular analysis of the aureothin biosynthesis gene cluster

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Oxidative cleavage of premithramycin B is one of the last steps in the biosynthesis of the antitumor drug mithramycin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Biosynthesis of the enediyne antitumor antibiotic C-1027

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Choosing the best pulse sequences, acquisition parameters, postacquisition processing strategies, and probes for natural product structure elucidation by NMR spectroscopy.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

AS-183, a novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Scedosporium sp. SPC-15549

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

A gamma-lactone form nafuredin, nafuredin-gamma, also inhibits helminth complex I.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Aurafuron A and B, new bioactive polyketides from Stigmatella aurantiaca and Archangium gephyra (Myxobacteria). Fermentation, isolation, physico-chemical properties, structure and biological activity

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents

1 reference

https://api.crossref.org/works/10.1038%2FJA.2006.24

7 January 2021

Identifiers

DOI

10.1038/JA.2006.24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 January 2020

1038953166

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16724457%20AND%20SRC:MED&resulttype=core&format=json